|
Delayed
Nasdaq
11:33:25 29/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 5.000 USD | -1.56% |
|
-3.47% | -64.76% |
| 04/09 | NextCure Enters Into Ninth Amendment To Lease Agreement And Vacates Premises At 8000 Virginia Manor Road | CI |
| 12/08 | RTW Biotech's Avere to go public in US in reverse merger with NextCure | AN |
| Market Cap | 2.33Cr 2.05Cr 1.94Cr 1.76Cr 3.3Cr 223.13Cr 3.33Cr 23Cr 8.98Cr 113.94Cr 8.73Cr 8.54Cr 366.66Cr | P/E 2026 * |
-0.8x | P/E 2027 * | -0.86x |
|---|---|---|---|---|---|
| Enterprise Value | 2.33Cr 2.05Cr 1.94Cr 1.76Cr 3.3Cr 223.13Cr 3.33Cr 23Cr 8.98Cr 113.94Cr 8.73Cr 8.54Cr 366.66Cr | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
91.36% | Yield 2026 * |
-
| Yield 2027 * | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| NXTC | Delayed | |
CBOE
| NXTC | Real-time |
Last Transcript: NextCure, Inc.
| 1 day | -1.56% | ||
| 1 week | -3.47% | ||
| Current month | -21.74% | ||
| 1 month | -21.74% | ||
| 3 months | +185.74% | ||
| 6 months | -49.49% | ||
| Current year | -64.76% |
| 1 week | 4.64 |  | 5.65 |
| 1 month | 4.64 | | 8.64 |
| Current year | 1.55 | | 14.65 |
| 1 year | 1.55 | | 15.74 |
| 3 years | 1.55 | | 30.84 |
| 5 years | 1.55 | | 110.16 |
| 10 years | 1.55 | | 1,308 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Richman
CEO | Chief Executive Officer | 65 | 01/12/2015 |
Steven Cobourn
DFI | Director of Finance/CFO | 63 | 01/01/2018 |
Udayan Guha
CTO | Chief Tech/Sci/R&D Officer | 54 | 01/03/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Richman
BRD | Director/Board Member | 65 | 01/12/2015 |
Elaine Jones
BRD | Director/Board Member | 71 | 01/12/2015 |
David Kabakoff
CHM | Chairman | 78 | 01/12/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/08/26 | Sell | Company | -30,000 | 0.6554% | ||
| 31/07/26 | Adar1 Capital Management LLC
| Buy | Company | 36,303 | 0.7931% | |
| 29/07/26 | Adar1 Capital Management LLC
| Buy | Company | 3,410 | 0.0944% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.56% | -3.47% | -13.64% | -67.70% | 2.33Cr | |
| -0.70% | -4.35% | +56.10% | +86.42% | 7.18TCr | |
| +0.45% | -0.82% | +38.81% | +84.19% | 6.01TCr | |
| +0.19% | +0.94% | +36.97% | +21.32% | 2.79TCr | |
| -1.55% | -4.13% | -18.23% | +358.73% | 2.57TCr | |
| -0.33% | -2.18% | +0.58% | -9.18% | 2.49TCr | |
| +0.65% | +1.67% | +26.47% | -7.62% | 2.09TCr | |
| +3.46% | +3.91% | +158.90% | +337.81% | 1.5TCr | |
| +0.77% | +0.96% | +44.71% | +168.70% | 1.45TCr | |
| +3.91% | -4.56% | -2.71% | +506.41% | 1.39TCr | |
| Average | +0.54% | -1.52% | +32.80% | +147.91% | 2.75TCr | |
| Weighted average by Cap. | +0.24% | -1.74% | +38.19% | +128.25% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -3.38Cr -2.98Cr -2.82Cr -2.56Cr -4.8Cr -324.33Cr -4.85Cr -34Cr -13Cr -165.62Cr -13Cr -12Cr -532.97Cr | -4.36Cr -3.85Cr -3.64Cr -3.31Cr -6.2Cr -418.85Cr -6.26Cr -44Cr -17Cr -213.88Cr -16Cr -16Cr -688.29Cr |
| Net Debt | - | - |
Employees
40
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/26/29 | $5.001 | -1.56% | 38,649 |
| 28/26/28 | $5.080 | 0.00% | 63,197 |
| 25/26/25 | $5.080 | -3.79% | 71,790 |
| 24/26/24 | $5.280 | +9.54% | 2,26,905 |
| 23/26/23 | $4.820 | -6.95% | 2,25,869 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
5.080USD
Average target price
20.00USD
Spread / Average Target
+293.70%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- NXTC Stock
Select your edition
All financial news and data tailored to specific country editions
